NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Retro Biosciences

Retro Biosciences

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.retro.bio/

Last Round

VC Round

May 22, 2026

Est. Valuation

$5B

Total Funding Raised

$180M

Company Overview

Retro Biosciences is a biotechnology company that develops therapeutics targeting cellular reprogramming, autophagy, and plasma-inspired mechanisms to extend healthy human lifespan.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

longevity biotechcellular reprogrammingprotein engineeringage-related diseasedrug discoveryanti-aginghealthspanAI drug discoverytherapeutic pipelinecellular rejuvenationAlzheimer's therapeuticsprotein designbiotech startuplife extensioncomputational biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Retro Biosciences Comparables

Compare Retro Biosciences with similar companies based on industry and business-model similarity.

Retro Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Altos Labs
92%
NewLimit
87%
Life Biosciences
79%

Retro Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 22, 2026
Series AJan 24, 2025
SeedApr 6, 2022

Key People

Founding team and executive leadership

"Joe Betts-LaCroix"

CEO i.e. ultimately responsible for the achieving our mission

Executive Team

Retro Biosciences Investors

Notable investors and investment history

Retro Biosciences investors
InvestorRounds
4P CapitalVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 22, 2025

    Developing AI model for cell-repairing proteins with OpenAI.

  • Jul 1, 2025

    A job posting for a Senior Accountant indicates the company has expanded operations to include international entities, requiring management of global accounting, consolidation, and audits.

Retro Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Retro Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Retro Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range96
Year Founded2021
Last FundingMay 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.